XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance beginning at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 $ 38,560,117 $ (45,222,302) $ 16,143,619
Balance beginning (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278      
Provision for compensation expense related to stock-based compensation 997,830 997,830
Exercise of stock options into common stock $ 32 261,473 261,505
Exercise of stock options into common stock (in Shares) 308,526      
Net income (Loss) 13,631,719 13,631,719
Balance ending at Dec. 31, 2022 $ 851,660 $ 21,952,000 $ 2,176 39,819,420 (31,590,583) 31,034,673
Balance ending (in Shares) at Dec. 31, 2022 170,332 21,952 21,750,804      
Provision for compensation expense related to stock-based compensation 1,677,708 1,677,708
Extension of warrants 917,581 917,581
Purchases of treasury stock $ (166,757) (166,757)
Purchases of treasury stock (in Shares) 0 0 0 164,029      
Exercise of stock options into common stock 1,185 1,185
Exercise of stock options into common stock (in Shares) 1,500      
Net income (Loss) (4,233,617) (4,233,617)
Balance ending at Dec. 31, 2023 $ 851,660 $ 21,952,000 $ 2,176 $ (166,757) $ 42,415,894 $ (35,824,200) $ 29,230,773
Balance ending (in Shares) at Dec. 31, 2023 170,332 21,952 21,752,304 164,029